144 related articles for article (PubMed ID: 36802170)
1. Synthesis of Chlorophosphoramidate Monomer Morpholinos and PMOs.
Kundu J; Ghosh U; Ghosh A; Pattanayak S; Das A; Sinha S
Curr Protoc; 2023 Feb; 3(2):e686. PubMed ID: 36802170
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Morpholino Monomers, Chlorophosphoramidate Monomers, and Solid-Phase Synthesis of Short Morpholino Oligomers.
Bhadra J; Pattanayak S; Sinha S
Curr Protoc Nucleic Acid Chem; 2015 Sep; 62():4.65.1-4.65.26. PubMed ID: 26380905
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Phosphorodiamidate Morpholino Oligonucleotides Using Trityl and Fmoc Chemistry in an Automated Oligo Synthesizer.
Kundu J; Ghosh A; Ghosh U; Das A; Nagar D; Pattanayak S; Ghose A; Sinha S
J Org Chem; 2022 Aug; 87(15):9466-9478. PubMed ID: 35839125
[TBL] [Abstract][Full Text] [Related]
4. C5-pyrimidine-functionalized morpholino oligonucleotides exhibit differential binding affinity, target specificity and lipophilicity.
Das A; Ghosh A; Sinha S
Org Biomol Chem; 2023 Feb; 21(6):1242-1253. PubMed ID: 36633261
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Backbone-Modified Morpholino Oligonucleotides Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513252
[TBL] [Abstract][Full Text] [Related]
6. Convergent synthesis of phosphorodiamidate morpholino oligonucleotides (PMOs) by the H-phosphonate approach.
Tsurusaki T; Sato K; Imai H; Hirai K; Takahashi D; Wada T
Sci Rep; 2023 Aug; 13(1):12576. PubMed ID: 37537221
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Phosphorodiamidate Morpholino Oligonucleotides and Their Chimeras Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
J Am Chem Soc; 2016 Dec; 138(48):15663-15672. PubMed ID: 27934012
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 5'-Thiol Functionalized Morpholino Oligo-Nucleotide and Subsequent Conjugation with IGT to Improve Delivery and Antisense Efficacy
Ghosh U; Gupta S; Sinha S
Bioconjug Chem; 2023 Jan; 34(1):174-180. PubMed ID: 36538654
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biophysical Properties of Triazole-Incorporated PMOs (TzPMOs): A Convergent, Click Ligation Approach.
Banerjee A; Das A; Ghosh A; Gupta A; Sinha S
J Org Chem; 2024 Mar; 89(5):2895-2903. PubMed ID: 38344977
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biophysical Studies of High-Affinity Morpholino Oligomers Containing G-Clamp Analogs.
Das A; Ghosh A; Kundu J; Egli M; Manoharan M; Sinha S
J Org Chem; 2023 Nov; 88(21):15168-15175. PubMed ID: 37843026
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Nucleobase-Functionalized Morpholino Monomers.
Nandi B; Pattanayak S; Paul S; Kundu J; Sinha S
Methods Mol Biol; 2019; 1973():107-130. PubMed ID: 31016698
[TBL] [Abstract][Full Text] [Related]
12. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
Deere J; Iversen P; Geller BL
Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
[TBL] [Abstract][Full Text] [Related]
13. Improved protocol for the synthesis of flexibly protected morpholino monomers from unprotected ribonucleosides.
Pattanayak S; Paul S; Nandi B; Sinha S
Nucleosides Nucleotides Nucleic Acids; 2012; 31(11):763-82. PubMed ID: 23145948
[TBL] [Abstract][Full Text] [Related]
14. Use of Arabinonucleosides for Development and Implementation of a Novel 2'-O-Protecting Group for Efficient Solid-Phase Synthesis and 2'-O-Deprotection of RNA Sequences.
Takahashi M; Cawrse BM; Grajkowski A; Beaucage SL
Curr Protoc; 2022 Jan; 2(1):e346. PubMed ID: 35030289
[TBL] [Abstract][Full Text] [Related]
15. Construction of nanostructured DNA harbouring phosphorodiamidate morpholino oligonucleotide for controlled tissue distribution in mice.
Takahashi Y; Araie Y; Nomura D; Takahashi Y; Sano K; Saji H; Takakura Y; Nishikawa M
J Drug Target; 2018 Apr; 26(4):373-381. PubMed ID: 28972806
[TBL] [Abstract][Full Text] [Related]
16. Sequencing of Morpholino Antisense Oligonucleotides Using Electron Capture Dissociation Mass Spectrometry.
Karasawa K; Duchoslav E; Burton L; Kawakami J; Baba T
Anal Chem; 2023 Nov; 95(44):16352-16358. PubMed ID: 37871344
[TBL] [Abstract][Full Text] [Related]
17. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
[TBL] [Abstract][Full Text] [Related]
19. Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy.
Stoodley J; Miraz DS; Jad Y; Fischer M; Wood MJA; Varela MA
Methods Mol Biol; 2023; 2587():209-237. PubMed ID: 36401033
[TBL] [Abstract][Full Text] [Related]
20. Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.
Sun X; Marque LO; Cordner Z; Pruitt JL; Bhat M; Li PP; Kannan G; Ladenheim EE; Moran TH; Margolis RL; Rudnicki DD
Hum Mol Genet; 2014 Dec; 23(23):6302-17. PubMed ID: 25035419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
